| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 410105JHGR |
| InChI Key | BOJKULTULYSRAS-OTESTREVSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H30O5 |
| Molecular Weight | 350.46 |
| AlogP | 1.96 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 86.99 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 25.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | - | 25 | |
|
Other cytosolic protein
|
- | 49600 | - | - | - | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group H
Nuclear hormone receptor subfamily 1 group H member 4
|
- | 9700-9700 | - | - | - | |
|
Transcription factor
|
- | 9700-9700 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 80 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Colitis, Ulcerative | 3 | D003093 | ClinicalTrials |
| Crohn Disease | 2 | D003424 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Multiple Sclerosis, Chronic Progressive | 1 | D020528 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 65408 |
| ChEMBL | CHEMBL186141 |
| DrugBank | DB05767 |
| EPA CompTox | DTXSID3045980 |
| FDA SRS | 410105JHGR |
| Guide to Pharmacology | 9675 |
| PubChem | 5318517 |
| SureChEMBL | SCHEMBL12056309 |
| ZINC | ZINC000003881797 |